©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
Angus W Jeffrey, School of Medicine, University of Notre Dame, Fremantle, WA 6160, Australia
Yi Huang, Leon A Adams, Gerry MacQuillan, Gary P Jeffrey, School of Medicine and Pharmacology, University of Western Australia, Perth, WA 6009, Australia
Yi Huang, Leon A Adams, Gerry MacQuillan, Gary P Jeffrey, Department of Hepatology, Sir Charles Gairdner Hospital, Perth, WA 6009, Australia
W Bastiaan de Boer, Department of Anatomical Pathology, PathWest, QEII Medical Centre, Perth, WA 6009, Australia
David Speers, Department of Microbiology, PathWest, QEII Medical Centre, Perth, WA 6009, Australia
John Joseph, Department of Biochemistry, PathWest, QEII Medical Centre, Perth, WA 6009, Australia
Author contributions: Jeffrey AW, Huang Y and Jeffrey GP were responsible for study design, data collection and analysis and manuscript preparation; de Boer WB, Adams LA, MacQuillan G, Speers D and Joseph J were involved in data interpretation and manuscript preparation.
Institutional review board statement: The study was reviewed and approved by the Sir Charles Gairdner Hospital Human Ethics Research Committee.
Informed consent statement: This manuscript did not require informed consent as the presented data is anonymized and risk of identification is low. This retrospective study complies with the NHMRC National Statement on Ethical Conduct in Human Research.
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Data sharing statement: No additional data is available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Angus W Jeffrey, School of Medicine, University of Notre Dame, 32 Mouat St, Fremantle, WA 6160, Australia. email@example.com
Telephone: +61-8-94330555 Fax: +61-8-94330544
Received: March 14, 2017
Peer-review started: March 15, 2017
First decision: April 14, 2017
Revised: May 8, 2017
Accepted: May 18, 2017
Article in press: May 19, 2017
Published online: July 8, 2017